Option 7: Leflunomide
Leflunomide is a DMARD that works by inhibiting the production of immune cells responsible for inflammation and joint damage in RA patients. This medication can be taken orally and is used to treat moderate to severe RA, either alone or in combination with other DMARDs.
Leflunomide has been shown to reduce inflammation, slow joint damage, and improve overall function in people with RA. However, as with other DMARDs, it may take several weeks to months before noticeable improvements occur.
Potential side effects of leflunomide include gastrointestinal upset, liver abnormalities, and an increased risk of infections. Regular blood tests and monitoring are recommended to ensure the medication is working effectively and safely. If you experience any side effects or have concerns about your treatment, it’s crucial to discuss them with your healthcare provider, as adjustments to your treatment plan may be necessary. (7)
